冠心宁片联合西药治疗慢性稳定性心绞痛合并抑郁症疗效及对SAQ 评分、5-HT 的影响
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R541.4;R749.4

基金项目:

嘉兴市科技计划(2019AD32182)


Curative Effect of Guanxinning Tablet Combined with Western Medicine for Chronic Stable Angina Pectoris Complicated with Depression and Its Effect on SAQ Scores and 5-HT
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察冠心宁片联合西药治疗慢性稳定性心绞痛(CSAP) 合并抑郁症的疗效及对西雅图心绞痛量表(SAQ) 评分、5-羟色胺(5-HT) 的影响。方法:选取80 例CSAP 合并抑郁症患者,按随机数字表法分为对照组及治疗组各40 例。对照组采用西药基础治疗,治疗组在对照组基础上联合冠心宁片治疗。2 组均连续治疗1 个月。比较2 组临床疗效,比较2 组治疗前后SAQ 评分、汉密尔顿抑郁量表(HAMD-17) 评分及中医证候积分、血清皮质醇(CORT)、去甲肾上腺素(NA)、5-HT 水平的变化,比较2 组治疗期间不良反应发生率。结果:对照组临床疗效总有效率为77.50%,治疗组总有效率为95.00%,2 组比较,差异有统计学意义(P<0.05)。治疗后,SAQ 评分均较治疗前上升,HAMD-17 评分及中医证候积分均较治疗前下降,差异均有统计学意义(P<0.05);治疗后,治疗组SAQ 评分高于对照组,HAMD-17 评分及中医证候积分均低于对照组,差异均有统计学意义(P<0.05)。治疗后,治疗组CORT 水平均较治疗前下降,NA、5-HT 水平均较治疗前上升,差异均有统计学意义(P<0.05);治疗后,治疗组CORT 水平低于对照组,NA、5-HT 水平均高于对照组,差异均有统计学意义(P<0.05)。对照组不良反应发生率为5.00%,治疗组不良反应发生率为7.50%,2 组比较,差异无统计学意义(P>0.05)。结论:冠心宁片联合西药治疗CSAP 合并抑郁症的临床疗效较好,可有效改善患者抑郁症状及心绞痛症状,提高其生活质量,用药安全性较高。

    Abstract:

    Abstract:Objective:To observe the curative effect of Guanxinning tablet combined with western medicine for chronic stable angina pectoris(CSAP) complicated with depression and its effect on Seattle Angina Questionnaire(SAQ) scores and 5-hydroxytryptamine(5-HT). Methods:A total of 80 cases of patients with CSAP complicated with depression were selected and divided into the control group and the treatment group according to the random number table method,with 40 cases in each group. The control group was treated with western medicine, and the treatment group was additionally treated with Guanxinning tablet based on the treatment of the control group. Both groups were treated for one month. The clinical effects in the two groups were compared;the changes in the scores of SAQ,Hamilton Depression Rating Scale(HAMD- 17) and Chinese medicine syndromes as well as the levels of cortisol(CORT),norepinephrine(NA) and 5-hydroxytryptamine(5-HT) in serum before and after treatment in the two groups were compared;the incidences of adverse reactions during treatment in the two groups were compared. Results: The total effective rate of clinical effect was 77.50% in the control group and 95.00% in the treatment group,the difference being significant(P<0.05). After treatment,SAQ scores were increased when compared with those before treatment, and the scores of HAMD- 17 and Chinese medicine syndromes were decreased, differences being significant(P<0.05). After treatment, the SAQ score in the treatment group was higher than that in the control group,and the scores of HAMD-17 and Chinese medicine syndromes were lower,differences being significant(P< 0.05). After treatment,CORT levels in the treatment group were decreased when compared with those before treatment, and the levels of NA and 5- HT were increased, differences being significant(P<0.05); the CORT level in the treatment group was lower than that in the control group,and the levels of NA and 5-HT were higher,differences being significant(P< 0.05). The incidence of adverse reactions was 5.00% in the control group and 7.50% in the treatment group,there being no significant difference between the two groups(P>0.05). Conclusion: The therapy of Guanxinning tablet combined with western medicine has a good clinical effect in the treatment of CSAP complicated with depression, which can effectively improve depressive symptoms,clinical Chinese medicine symptoms and quality of life,with high medication safety.

    参考文献
    相似文献
    引证文献
引用本文

钱承嗣,费玉娥,孙燕.冠心宁片联合西药治疗慢性稳定性心绞痛合并抑郁症疗效及对SAQ 评分、5-HT 的影响[J].新中医,2022,54(9):52-55

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-05-09
  • 出版日期:
文章二维码